1.
Boongird S, Setthaudom C, Kitpermkiat R, Prasongtanakij S, Srisala S, Chuengsaman P, Nongnuch A, Nongnuch A, Assanatham M, Kiertiburanakul S, Malathum K, Phuphuakrat A, Bruminhent J. Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients. J Nephrol Soc Thail [Internet]. 2022 Dec. 29 [cited 2024 May 6];28(4):69-70. Available from: https://he01.tci-thaijo.org/index.php/JNST/article/view/260762